Current Illinois CancerCare Clinical Trials

TEMPUS SCLC OBSERVATIONAL STUDY: A Tissue and Longitudinal Circulating Tumor DNA (ctDNA) Biomarker Profiling Study of Patients with Small Cell Lung Cancer (SCLC) Using Comprehensive Next-Generation Sequencing (NGS) Assays” (Sculptor)

Study Number: TP-CA-003

Study Summary:
The study is a non-interventional evaluation of participants with SCLC who will receive diagnostic and (where possible) post-progression tumor tissue profiling, alongside plasma ctDNA biomarker profiling in addition to their standard of care therapy and disease surveillance.

Status: Open

Bloomington, Canton, Ottawa, Pekin, Peoria, Peru, Washington clinics

Study Coordinator(s)
  • Trupti, 309-243-3662, tsherbet@illinoiscancercare.com

Study Link

« Search Again